The AlphaNet® Alpha-1 Disease Management and Prevention Program (ADMAPP) is the only fully integrated disease management program shown to improve patient outcomes1,2*
Disease management health outcomes study results:
*2-year study comparing outcomes in a 12-month observation period with augmentation therapy alone and a 12-month intervention period with augmentation therapy plus ADMAPP2.
- Participants were members of AlphaNet, a not-for-profit health management company founded by alphas to provide comprehensive care solely for alphas
- 97% of ADMAPP study participants were taking PROLASTIN® (alpha1-proteinase inhibitor [human])2